When should lasers be used to treat melasma? Mildred López Piñeiro, M.D. provides her insight in our new column on energy devices.
A growing body of evidence supports treating melasma with systemic or intradermal tranexamic acid. But melasma patients often relapse when they stop taking the antifibrinolytic agent, and research on tranexamic acid’s long-term efficacy and safety is limited.
A literature review on clinical evidence for melasma treatments suggests an evidence-based treatment ladder.
A small study examines platelet-rich plasma injection as alternative or adjuvant melasma treatment.
Patients with pigmentary disorders suffer high frequency of psychological disturbances, including anxiety and depression.
The methods and products used to combat the day-to-day impacts of melasma has expanded to include tranexamic acid, cysteamine, along others.
New research has shed light on how hyperpigmentation occurs. Experts break down what you need to know in this article.
From sunscreen in a stick to niacinamide, and a non-hydroquinone, retinol-free skin tone corrector, these are among the promising treatments for hyperpigmentation.
It’s becoming clear that treating hyperpigmentation is much more than targeting the tyrosinase enzyme with topical hydroquinone.
Dermatologist R. Sonia Batra sits down with Dermatology Times for a melasma Q&A.